MLYS

MLYS R&D Expenses

$301.59MTTM · USD

Period ending:

MLYS FY R&D ExpensesUSD
MLYS FY R&D Expenses2020-12-31: $2.41M2021-12-31: $16.31M2022-12-31: $26.25M2023-12-31: $70.36M2024-12-31: $168.58M2025-12-31: $132.01M$168.58M$0.00
2020-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

MLYS r&d expenses history

Research and development spending. The available annual fiscal periods series contains 6 observations from Dec 31, 2020 to Dec 31, 2025.

Mineralys Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
132,009,000
168,581,000
70,361,000
26,250,000
16,308,000
2,411,000

Compare r&d expenses

All MLYS financial metrics · MLYS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.